{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:00:20Z","timestamp":1793678420418,"version":"4.5.1"},"reference-count":219,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:00:00Z","timestamp":1714953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaut.2024.103247","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T08:05:45Z","timestamp":1715328345000},"page":"103247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["The immunopathogenesis of sarcoidosis"],"prefix":"10.1016","volume":"149","author":[{"given":"Jelle","family":"Miedema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cinetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Smed-S\u00f6rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Spagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.4049\/jimmunol.181.1.746","article-title":"The anergic state in sarcoidosis is associated with diminished dendritic cell function","volume":"181","author":"Mathew","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib3","first-page":"49","article-title":"Localization of the immune response in sarcoidosis","volume":"120","author":"Hunninghake","year":"1979","journal-title":"Am. Rev. Respir. Dis."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/0003-4819-92-3-406","article-title":"Immunologic abnormalities in sarcoidosis","volume":"92","author":"Daniele","year":"1980","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.jaut.2024.103247_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJM198108203050804","article-title":"Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity","volume":"305","author":"Hunninghake","year":"1981","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jaut.2024.103247_bib6","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/rccm.202006-2261ED","article-title":"The ABCs of granulomatous lung diseases: age-associated B cells","volume":"202","author":"Polverino","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12016-015-8479-6","article-title":"Pathology of sarcoidosis","volume":"49","author":"Rossi","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib8","first-page":"110","article-title":"T-lymphocyte activity in HLA-DR17 positive patients with active and clinically recovered sarcoidosis","volume":"20","author":"Planck","year":"2003","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.200909-1451OC","article-title":"Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis","volume":"182","author":"Prasse","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8480-0","article-title":"Sarcoidosis: a critical review of history and milestones","volume":"49","author":"Spagnolo","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2024.103247_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106161","article-title":"Current perspectives on the immunopathogenesis of sarcoidosis","volume":"173","author":"Lee","year":"2020","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MOH.0000000000000301","article-title":"Mechanism of granuloma formation in sarcoidosis","volume":"24","author":"Sakthivel","year":"2017","journal-title":"Curr. Opin. Hematol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12016-015-8477-8","article-title":"Immunogenetics of disease-causing inflammation in sarcoidosis","volume":"49","author":"Grunewald","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jaut.2024.103247_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2017.12.012","article-title":"Th17-lineage cells in pulmonary sarcoidosis and Lofgren's syndrome: friend or foe?","volume":"87","author":"Miedema","year":"2018","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/MCP.0000000000000303","article-title":"T-cell immunology in sarcoidosis: disruption of a delicate balance between helper and regulatory T-cells","volume":"22","author":"Broos","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib16","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1183\/09031936.00089910","article-title":"T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis","volume":"38","author":"Kriegova","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"7198","key":"10.1016\/j.jaut.2024.103247_bib17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01124-2017","article-title":"Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes","volume":"51","author":"Broos","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1183\/09031936.00039714","article-title":"Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes","volume":"44","author":"Su","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib20","first-page":"1959","article-title":"Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ","volume":"142","author":"North","year":"1993","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1074-7613(02)00475-2","article-title":"Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos","volume":"17","author":"Davis","year":"2002","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clim.2009.05.001","article-title":"Granulomatous disease in common variable immunodeficiency","volume":"133","author":"Ardeniz","year":"2009","journal-title":"Clin Immunol"},{"issue":"19","key":"10.1016\/j.jaut.2024.103247_bib23","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa073966","article-title":"An immunodeficiency disease with RAG mutations and granulomas","volume":"358","author":"Schuetz","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1165\/rcmb.2018-0053OC","article-title":"IL-13-regulated macrophage polarization during granuloma formation in an in vitro human sarcoidosis model","volume":"60","author":"Locke","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2024.103247_bib26","first-page":"491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Arango","year":"2014","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib27","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/cei.12138","article-title":"Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis","volume":"173","author":"Gabrilovich","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2024.103247_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.822094","article-title":"Transcriptome analysis of peripheral blood mononuclear cells in pulmonary sarcoidosis","volume":"9","author":"Yoshioka","year":"2022","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1399-0039.2011.01808.x","article-title":"Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis","volume":"79","author":"Veltkamp","year":"2012","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/qjmed\/hcx243","article-title":"Toll-like receptor 3 L412F polymorphism promotes a persistent clinical phenotype in pulmonary sarcoidosis","volume":"111","author":"Cooke","year":"2018","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib31","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1165\/rcmb.2015-0278OC","article-title":"Functional toll-like receptor 9 expression and CXCR3 ligand release in pulmonary sarcoidosis","volume":"55","author":"Schnerch","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jaut.2024.103247_bib32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev-immunol-032712-100022","article-title":"The Formation and function of granulomas","volume":"36","author":"Pagan","year":"2018","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib33","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03468-2020","article-title":"Monocytes in sarcoidosis are potent tumour necrosis factor producers and predict disease outcome","volume":"58","author":"Lepzien","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.humimm.2017.10.009","article-title":"Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: a new aspect of macrophage heterogeneity","volume":"79","author":"Shamaei","year":"2018","journal-title":"Hum. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2024.103247_bib35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/cup.13675","article-title":"CD163-positive macrophage infiltration predicts systemic involvement in sarcoidosis","volume":"47","author":"Isohisa","year":"2020","journal-title":"J. Cutan. Pathol."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib36","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ajpath.2010.11.065","article-title":"M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis","volume":"178","author":"Prokop","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"19","key":"10.1016\/j.jaut.2024.103247_bib37","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030478","article-title":"An mTORC1-dependent mouse model for cardiac sarcoidosis","volume":"12","author":"Bueno-Beti","year":"2023","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"issue":"7966","key":"10.1016\/j.jaut.2024.103247_bib39","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41586-023-06002-x","article-title":"Physiology and diseases of tissue-resident macrophages","volume":"618","author":"Lazarov","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.09.054","article-title":"DNA damage signaling instructs polyploid macrophage fate in granulomas","volume":"167","author":"Herrtwich","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41467-020-14285-1","article-title":"Environmental arginine controls multinuclear giant cell metabolism and formation","volume":"11","author":"Brunner","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2003-0304RC","article-title":"Peroxisome proliferator-activated receptor gamma activity is deficient in alveolar macrophages in pulmonary sarcoidosis","volume":"30","author":"Culver","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"9","key":"10.1016\/j.jaut.2024.103247_bib43","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.4049\/jimmunol.0803504","article-title":"Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response","volume":"182","author":"Malur","year":"2009","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib44","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.it.2020.01.007","article-title":"Sarcoidosis and the mTOR, Rac1, and autophagy triad","volume":"41","author":"Pacheco","year":"2020","journal-title":"Trends Immunol."},{"issue":"23","key":"10.1016\/j.jaut.2024.103247_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171088","article-title":"Activation of the pentose phosphate pathway in macrophages is crucial for granuloma formation in sarcoidosis","volume":"133","author":"Nakamizo","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.jaut.2024.103247_bib46","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1164\/rccm.200912-1855OC","article-title":"Gene set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis","volume":"181","author":"Lockstone","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2024.103247_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.719009","article-title":"Hypoxia promotes a mixed inflammatory-fibrotic macrophages phenotype in active sarcoidosis","volume":"12","author":"Jeny","year":"2021","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.jaut.2024.103247_bib48","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/onc.2014.164","article-title":"mTORC1 drives HIF-1alpha and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3","volume":"34","author":"Dodd","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.jaut.2024.103247_bib49","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44519","article-title":"HIF-1alpha regulates IL-1beta and IL-17 in sarcoidosis","volume":"8","author":"Talreja","year":"2019","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72067-7","article-title":"Sarcoidosis exosomes stimulate monocytes to produce pro-inflammatory cytokines and CCL2","volume":"10","author":"Wahlund","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jaut.2024.103247_bib51","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.humimm.2012.05.005","article-title":"Changed phagocytic activity and pattern of Fcgamma and complement receptors on blood monocytes in sarcoidosis","volume":"73","author":"Dubaniewicz","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jaut.2024.103247_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.562564","article-title":"Local and systemic concentrations of pattern recognition receptors of the lectin pathway of complement in a cohort of patients with interstitial lung diseases","volume":"11","author":"Vogt","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jaut.2024.103247_bib53","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1164\/rccm.202112-2771OC","article-title":"Pentraxin 3 inhibits complement-driven macrophage activation to restrain granuloma formation in sarcoidosis","volume":"206","author":"Goncales","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.jaut.2024.103247_bib55","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.cell.2020.12.008","article-title":"Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease","volume":"183","author":"Lee","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib56","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00119-2019","article-title":"The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation","volume":"55","author":"Huppertz","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2024.103247_bib57","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","article-title":"Dendritic cells revisited","volume":"39","author":"Cabeza-Cabrerizo","year":"2021","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib59","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20100348","article-title":"Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells","volume":"207","author":"Bachem","year":"2010","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib60","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J. Exp. Med."},{"issue":"6335","key":"10.1016\/j.jaut.2024.103247_bib61","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.immuni.2020.07.003","article-title":"Differential IRF8 transcription factor requirement defines two pathways of dendritic cell development in humans","volume":"53","author":"Cytlak","year":"2020","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.immuni.2020.06.002","article-title":"Transcriptional and functional analysis of CD1c(+) human dendritic cells identifies a CD163(+) subset priming CD8(+)CD103(+) T cells","volume":"53","author":"Bourdely","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib64","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.immuni.2019.08.008","article-title":"Single-cell analysis of human mononuclear phagocytes reveals subset-defining markers and identifies circulating inflammatory dendritic cells","volume":"51","author":"Dutertre","year":"2019","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1139","article-title":"Plasmacytoid dendritic cell biology and its role in immune-mediated diseases","volume":"9","author":"Ye","year":"2020","journal-title":"Clin Transl Immunology"},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib66","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1165\/rcmb.2017-0051PS","article-title":"Dendritic cell trafficking and function in rare lung diseases","volume":"57","author":"Liu","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib67","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.immuni.2017.02.019","article-title":"Dendritic cells display subset and tissue-specific maturation dynamics over human life","volume":"46","author":"Granot","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4049\/jimmunol.1002358","article-title":"Dendritic cells distinguish individual chemokine signals through CCR7 and CXCR4","volume":"186","author":"Ricart","year":"2011","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib69","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1084\/jem.188.2.373","article-title":"Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites","volume":"188","author":"Dieu","year":"1998","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib70","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/eji.1830260323","article-title":"Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells","volume":"26","author":"Heufler","year":"1996","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib71","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ni.1613","article-title":"A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses","volume":"9","author":"Volpe","year":"2008","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.jaut.2024.103247_bib72","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nri3712","article-title":"Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny","volume":"14","author":"Guilliams","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jaut.2024.103247_bib73","first-page":"13","article-title":"A novel method for isolating dendritic cells from human bronchoalveolar lavage fluid","volume":"351","author":"Ten","year":"2009","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib74","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cell.2010.09.039","article-title":"Microbial stimulation fully differentiates monocytes to DC-SIGN\/CD209(+) dendritic cells for immune T cell areas","volume":"143","author":"Cheong","year":"2010","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib75","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.immuni.2012.10.016","article-title":"Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen","volume":"38","author":"Plantinga","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib76","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/JLB.5A0718-280RR","article-title":"Mapping mononuclear phagocytes in blood, lungs, and lymph nodes of sarcoidosis patients","volume":"105","author":"Lepzien","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib77","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1465-9921-13-33","article-title":"Evidence for local dendritic cell activation in pulmonary sarcoidosis","volume":"13","author":"Ten Berge","year":"2012","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib78","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","article-title":"Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species","volume":"45","author":"Guilliams","year":"2016","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.jaut.2024.103247_bib79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nri.2016.115","article-title":"Dendritic cells: sorting, sorted","volume":"16","author":"Bordon","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib80","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/thx.2003.006049","article-title":"Involvement of dendritic cells in sarcoidosis","volume":"59","author":"Ota","year":"2004","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib81","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1465-9921-14-29","article-title":"Comparative analysis of circulating dendritic cell subsets in patients with atopic diseases and sarcoidosis","volume":"14","author":"Hayashi","year":"2013","journal-title":"Respir. Res."},{"key":"10.1016\/j.jaut.2024.103247_bib82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1465-9921-13-33","article-title":"Evidence for local dendritic cell activation in pulmonary sarcoidosis","volume":"13","author":"Ten Berge","year":"2012","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib83","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1183\/09031936.00036307","article-title":"Airway dendritic cell phenotypes in inflammatory diseases of the human lung","volume":"30","author":"Lommatzsch","year":"2007","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib84","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/JLB.5A0321-162R","article-title":"Pulmonary and blood dendritic cells from sarcoidosis patients more potently induce IFNgamma-producing Th1 cells compared with monocytes","volume":"111","author":"Lepzien","year":"2022","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib86","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/cei\/uxad052","article-title":"Peripheral blood lymphopenia in sarcoidosis associates with HLA-DRB1 alleles but not with lung immune cells and organ involvement","volume":"213","author":"Darlington","year":"2023","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a75007e1-492a-4bcb-80a8-28b4d432c099","article-title":"Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib88","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-018-0001-y","article-title":"The full spectrum of human naive T cells","volume":"18","author":"van den Broek","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2024.103247_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.567342","article-title":"Single cell transcriptomics implicate novel monocyte and T cell immune dysregulation in sarcoidosis","volume":"11","author":"Garman","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103247_bib90","article-title":"Circulating T cells in sarcoidosis have an aberrantly activated phenotype that correlates with disease outcome (submitted)","author":"Miedema","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2024.103247_bib91","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3642832","article-title":"Local and systemic CD4(+) T cell exhaustion reverses with clinical resolution of pulmonary sarcoidosis","volume":"2017","author":"Hawkins","year":"2017","journal-title":"J Immunol Res"},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib92","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1164\/rccm.201401-0188OC","article-title":"Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity","volume":"190","author":"Braun","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib93","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1365-2249.2000.01365.x","article-title":"Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells","volume":"122","author":"Prasse","year":"2000","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib94","first-page":"487","article-title":"Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis","volume":"56","author":"Mollers","year":"2001","journal-title":"Thorax"},{"issue":"11","key":"10.1016\/j.jaut.2024.103247_bib95","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-gamma-Producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib96","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thx.54.4.339","article-title":"Phenotypic analysis of lymphocytes and monocytes\/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis","volume":"54","author":"Wahlstrom","year":"1999","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.jaut.2024.103247_bib97","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1164\/ajrccm.163.7.2005028","article-title":"Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis","volume":"163","author":"Katchar","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib98","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4049\/jimmunol.166.1.642","article-title":"IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs","volume":"166","author":"Shigehara","year":"2001","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib99","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2249.2007.03423.x","article-title":"CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages","volume":"149","author":"Nishioka","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.jaut.2024.103247_bib100","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.161.11.6413","article-title":"Involvement of the IP-10 chemokine in sarcoid granulomatous reactions","volume":"161","author":"Agostini","year":"1998","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib101","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1183\/09031936.00157508","article-title":"CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis","volume":"34","author":"Busuttil","year":"2009","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib102","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/thx.52.5.431","article-title":"Analysis of T cell subsets and beta chemokines in patients with pulmonary sarcoidosis","volume":"52","author":"Iida","year":"1997","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib103","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1183\/09031936.02.00289902","article-title":"CC and C chemokine expression in pulmonary sarcoidosis","volume":"20","author":"Petrek","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib104","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-2478(01)00324-8","article-title":"CC chemokine receptor 5 (CCR5) mRNA expression in pulmonary sarcoidosis","volume":"80","author":"Petrek","year":"2002","journal-title":"Immunol. Lett."},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib105","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1164\/rccm.201503-0635LE","article-title":"Decreased cytotoxic T-lymphocyte antigen 4 expression on regulatory T cells and Th17 cells in sarcoidosis: double trouble?","volume":"192","author":"Broos","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib106","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1183\/13993003.00092-2016","article-title":"Expanded lung T-bet+RORgammaT+ CD4+ T-cells in sarcoidosis patients with a favourable disease phenotype","volume":"48","author":"Kaiser","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib107","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/cei.12403","article-title":"Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Lofgren's syndrome","volume":"178","author":"Ostadkarampour","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib108","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1084\/jem.20130301","article-title":"Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids","volume":"211","author":"Ramesh","year":"2014","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib109","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","volume":"18","author":"Tanaka","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib110","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41467-022-30615-x","article-title":"Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis","volume":"13","author":"Damsky","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib111","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/acr2.11112","article-title":"Treatment of multiorgan sarcoidosis with tofacitinib","volume":"2","author":"Damsky","year":"2020","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib112","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jaut.2024.103247_bib113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of treg-mediated T cell suppression","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib114","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12931-015-0265-8","article-title":"Impaired survival of regulatory T cells in pulmonary sarcoidosis","volume":"16","author":"Broos","year":"2015","journal-title":"Respir. Res."},{"key":"10.1016\/j.jaut.2024.103247_bib115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jaut.2018.07.012","article-title":"Molecular profiling of regulatory T cells in pulmonary sarcoidosis","volume":"94","author":"Kachamakova-Trojanowska","year":"2018","journal-title":"J. Autoimmun."},{"issue":"11","key":"10.1016\/j.jaut.2024.103247_bib116","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.4049\/jimmunol.1202891","article-title":"Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis","volume":"190","author":"Oswald-Richter","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2024.103247_bib117","article-title":"Imbalanced distribution of regulatory T cells and Th17.1 cells in the peripheral blood and BALF of sarcoidosis patients: relationship to disease activity and the fibrotic radiographic phenotype","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib118","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.chest.2021.04.032","article-title":"Inhibiting OX40 restores regulatory T-cell function and suppresses inflammation in pulmonary sarcoidosis","volume":"160","author":"Kumari","year":"2021","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib119","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/cei.12715","article-title":"Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS\/ICOS-ligand axis in disease course and resolution","volume":"183","author":"Sakthivel","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cardfail.2021.07.008","article-title":"Rituximab for the treatment of refractory cardiac sarcoidosis: a single-center experience","volume":"28","author":"Elwazir","year":"2022","journal-title":"J. Card. Fail."},{"issue":"8","key":"10.1016\/j.jaut.2024.103247_bib121","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/CVI.05118-11","article-title":"Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis","volume":"18","author":"Lee","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib122","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/rccm.201206-1024OC","article-title":"Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis?","volume":"187","author":"Kamphuis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib123","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41598-020-57741-0","article-title":"Imbalance in B cell and T Follicular helper cell subsets in pulmonary sarcoidosis","volume":"10","author":"Kudryavtsev","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.jaut.2024.103247_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043588","article-title":"Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels","volume":"7","author":"Saussine","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib125","first-page":"72","article-title":"Serum B cell activating factor (BAFF) and sarcoidosis activity","volume":"36","author":"Hashemzadeh","year":"2021","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.jaut.2024.103247_bib126","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3389\/fimmu.2018.01516","article-title":"In situ humoral immunity to vimentin in HLA-DRB1*03(+) patients with pulmonary sarcoidosis","volume":"9","author":"Kinloch","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib127","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/cei.13635","article-title":"Adaptive immune system in pulmonary sarcoidosis-Comparison of peripheral and alveolar biomarkers","volume":"205","author":"d'Alessandro","year":"2021","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2024.103247_bib129","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3389\/fimmu.2018.01097","article-title":"Relapsing-remitting multiple sclerosis is characterized by a T follicular cell pro-inflammatory shift, reverted by dimethyl fumarate treatment","volume":"9","author":"Cunill","year":"2018","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jaut.2024.103247_bib130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075319","article-title":"Circulating TFH subset distribution is strongly affected in lupus patients with an active disease","volume":"8","author":"Le Coz","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jaut.2024.103247_bib131","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/rccm.202012-4423OC","article-title":"Follicular helper-like T cells in the lung highlight a novel role of B cells in sarcoidosis","volume":"204","author":"Bauer","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib132","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2023.01.014","article-title":"Single-cell and spatial transcriptomics reveal aberrant lymphoid developmental programs driving granuloma formation","volume":"56","author":"Krausgruber","year":"2023","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib133","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1183\/09031936.05.00030805","article-title":"Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients","volume":"26","author":"Katchar","year":"2005","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2024.103247_bib134","article-title":"Characterization of natural killer and T cells in bronchoalveolar lavage and peripheral blood of sarcoidosis patients","volume":"13","author":"Bergantini","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib135","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/cyto.b.20120","article-title":"Prognostic value of neutrophils and NK cells in bronchoalveolar lavage of sarcoidosis","volume":"70","author":"Tutor-Ureta","year":"2006","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jaut.2024.103247_bib136","article-title":"Predictive role of natural killer cells in bronchoalveolar lavage fluid of patients with sarcoidosis","author":"Bergantini","year":"2024","journal-title":"Pulmonology"},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib137","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1183\/09031936.99.13613459","article-title":"Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis?","volume":"13","author":"Drent","year":"1999","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jaut.2024.103247_bib138","article-title":"Neutrophils in bronchoalveolar lavage fluid indicating the severity and relapse of pulmonary sarcoidosis","volume":"8","author":"Feng","year":"2021","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib139","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1189\/jlb.3HI1014-493R","article-title":"Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis","volume":"98","author":"Gregory","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib140","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joim.12991","article-title":"Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database","volume":"288","author":"Cohen Aubart","year":"2020","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib141","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.chest.2018.03.056","article-title":"Drug-induced sarcoidosis-like reactions","volume":"154","author":"Chopra","year":"2018","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib142","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MCP.0000000000000800","article-title":"Drug-induced sarcoidosis-like reactions","volume":"27","author":"Miedema","year":"2021","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"9","key":"10.1016\/j.jaut.2024.103247_bib143","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1007\/s10067-021-05654-2","article-title":"Adalimumab-induced sarcoidosis-like reaction involving oral cavity in rheumatoid arthritis: a case-based review","volume":"40","author":"Rodrigues-Fernandes","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.jaut.2024.103247_bib144","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13075-016-1197-5","article-title":"Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis","volume":"18","author":"Hull","year":"2016","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib146","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/art.27203","article-title":"Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells","volume":"62","author":"Ma","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.jaut.2024.103247_bib147","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrgastro.2012.125","article-title":"Paradoxical inflammation induced by anti-TNF agents in patients with IBD","volume":"9","author":"Cleynen","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib148","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1742-1241.2005.00651.x","article-title":"Interferon-induced sarcoidosis","volume":"60","author":"Alazemi","year":"2006","journal-title":"Int. J. Clin. Pract."},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib149","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm.2110","article-title":"T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis","volume":"16","author":"Axtell","year":"2010","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.jaut.2024.103247_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102587","article-title":"Sarcoidosis related to checkpoint and BRAF\/MEK inhibitors in melanoma","volume":"19","author":"Rubio-Rivas","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.jaut.2024.103247_bib151","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/1756-185X.13076","article-title":"Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: case series and immunophenotypic analysis","volume":"20","author":"Lomax","year":"2017","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib152","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41375-023-01824-0","article-title":"Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma","volume":"37","author":"Leipold","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.jaut.2024.103247_bib153","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.rmed.2019.01.015","article-title":"The development of sarcoidosis in patients receiving daclizumab: a case series from multiple clinical trials","volume":"149","author":"Judson","year":"2019","journal-title":"Respir. Med."},{"issue":"13","key":"10.1016\/j.jaut.2024.103247_bib154","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1177\/1352458518790391","article-title":"Sarcoidosis following alemtuzumab treatment for multiple sclerosis","volume":"24","author":"Willis","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jaut.2024.103247_bib155","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X19841796","article-title":"New-onset cutaneous sarcoidosis under tocilizumab treatment for giant cell arteritis: a quasi-paradoxical adverse drug reaction. Case report and literature review","volume":"11","author":"Del Giorno","year":"2019","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib156","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1574886315666200316113312","article-title":"Ustekinumab-induced sarcoidosis in a patient with psoriatic arthritis","volume":"15","author":"Kobak","year":"2020","journal-title":"Curr. Drug Saf."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib157","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-240615","article-title":"Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis","volume":"14","author":"Kirby","year":"2021","journal-title":"BMJ Case Rep."},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib158","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1590\/S1413-86702011000600018","article-title":"Immune reconstitution inflammatory syndrome associated with pulmonary sarcoidosis in an HIV-infected patient: an immunohistochemical study","volume":"15","author":"Miranda","year":"2011","journal-title":"Braz. J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib159","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jinf.2005.05.009","article-title":"Coexistent sarcoidosis and HIV infection: an immunological paradox?","volume":"52","author":"Almeida","year":"2006","journal-title":"J. Infect."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib160","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1378\/chest.124.3.929","article-title":"Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence","volume":"124","author":"Morris","year":"2003","journal-title":"Chest"},{"issue":"5322","key":"10.1016\/j.jaut.2024.103247_bib161","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1126\/science.277.5322.112","article-title":"Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease","volume":"277","author":"Autran","year":"1997","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib162","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/381094","article-title":"Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy","volume":"38","author":"Foulon","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib163","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib164","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MCP.0000000000000301","article-title":"From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis","volume":"22","author":"Bonham","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"9","key":"10.1016\/j.jaut.2024.103247_bib165","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"14","key":"10.1016\/j.jaut.2024.103247_bib166","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/15353702231182224","article-title":"Interleukin-17A plays a key role in pulmonary fibrosis following Propionibacterium acnes-induced sarcoidosis-like inflammation","volume":"248","author":"Jiang","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030585","article-title":"Elevated serum amyloid a levels are not specific for sarcoidosis but associate with a fibrotic pulmonary phenotype","volume":"10","author":"Beijer","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaut.2024.103247_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108784","article-title":"Serum amyloid A\/anti-CCL20 induced the rebalance of Th17\/regulatory T cells in SodA-induced sarcoidosis","volume":"109","author":"Meng","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib169","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.trsl.2012.03.005","article-title":"The clinical and immunologic features of pulmonary fibrosis in sarcoidosis","volume":"160","author":"Patterson","year":"2012","journal-title":"Transl. Res."},{"issue":"9","key":"10.1016\/j.jaut.2024.103247_bib170","doi-asserted-by":"crossref","first-page":"637","DOI":"10.14348\/molcells.2014.0150","article-title":"Regulation of wound healing and fibrosis by hypoxia and hypoxia-inducible factor-1","volume":"37","author":"Ruthenborg","year":"2014","journal-title":"Mol Cells"},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib171","doi-asserted-by":"crossref","first-page":"L740","DOI":"10.1152\/ajplung.00146.2010","article-title":"Hypoxia-inducible factor-1alpha mediates TGF-beta-induced PAI-1 production in alveolar macrophages in pulmonary fibrosis","volume":"300","author":"Ueno","year":"2011","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib172","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0036-1586228","article-title":"The role of plasminogen activator inhibitor type-1 in fibrosis","volume":"43","author":"Flevaris","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"issue":"7","key":"10.1016\/j.jaut.2024.103247_bib173","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200509-1518OC","article-title":"A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18","volume":"173","author":"Prasse","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105530","article-title":"A novel mechanoeffector role of fibroblast S100A4 in myofibroblast transdifferentiation and fibrosis","volume":"300","author":"Southern","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2024.103247_bib175","article-title":"Evaluation of CD163 expression on alveolar macrophages from BAL of patients with fibrotic lung diseases","author":"Vasarmidi","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib176","first-page":"120","article-title":"Th1 and Th2 responses regulate experimental lung granuloma development","volume":"13","author":"Kunkel","year":"1996","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib177","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.cyto.2012.12.016","article-title":"Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease","volume":"61","author":"Patterson","year":"2013","journal-title":"Cytokine"},{"issue":"166","key":"10.1016\/j.jaut.2024.103247_bib178","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0178-2022","article-title":"Immune mechanisms in fibrotic pulmonary sarcoidosis","volume":"31","author":"Weeratunga","year":"2022","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.jaut.2024.103247_bib179","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib180","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69281-8","article-title":"Novel protein pathways in development and progression of pulmonary sarcoidosis","volume":"10","author":"Bhargava","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib181","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1164\/rccm.202308-1331LE","article-title":"Genome and transcriptome-wide association study of fibrotic sarcoidosis in European Americans","volume":"209","author":"Liao","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6029","key":"10.1016\/j.jaut.2024.103247_bib182","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.jaut.2024.103247_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2020.100575","article-title":"Safety and efficacy of abatacept in patients with treatment-resistant SARCoidosis (ABASARC) - protocol for a multi-center, single-arm phase IIa trial","volume":"19","author":"Frye","year":"2020","journal-title":"Contemp Clin Trials Commun"},{"issue":"11","key":"10.1016\/j.jaut.2024.103247_bib184","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa050524","article-title":"Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition","volume":"353","author":"Genovese","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2024.103247_bib185","article-title":"The role of diverse immune cells in sarcoidosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jaut.2024.103247_bib186","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/rheumatology\/ket186","article-title":"Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity","volume":"52","author":"Ueda-Hayakawa","year":"2013","journal-title":"Rheumatology"},{"issue":"32","key":"10.1016\/j.jaut.2024.103247_bib187","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib188","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12948-015-0025-9","article-title":"Rituximab in refractory sarcoidosis: a single centre experience","volume":"13","author":"Cinetto","year":"2015","journal-title":"Clin. Mol. Allergy"},{"issue":"5","key":"10.1016\/j.jaut.2024.103247_bib189","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1183\/09031936.00224513","article-title":"Rituximab in the treatment of refractory pulmonary sarcoidosis","volume":"43","author":"Sweiss","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib190","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.jaut.2024.103247_bib191","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11122002","article-title":"JAK-STAT signaling: a double-edged sword of immune regulation and cancer progression","volume":"11","author":"Owen","year":"2019","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib192","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clim.2009.04.010","article-title":"Hypothesis: sarcoidosis is a STAT1-mediated disease","volume":"132","author":"Rosenbaum","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaut.2024.103247_bib193","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.gene.2016.09.037","article-title":"Bioinformatics analysis of gene expression profile data to screen key genes involved in pulmonary sarcoidosis","volume":"596","author":"Li","year":"2017","journal-title":"Gene"},{"issue":"26","key":"10.1016\/j.jaut.2024.103247_bib194","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","article-title":"Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis","volume":"379","author":"Damsky","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jaut.2024.103247_bib195","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01482-2018","article-title":"Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia","volume":"52","author":"Rotenberg","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.jaut.2024.103247_bib196","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/annrheumdis-2020-217271","article-title":"Steroid-resistant sarcoidosis treated with baricitinib","volume":"79","author":"Scheinberg","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103247_bib197","first-page":"1","article-title":"IL-6 signal transduction and its physiological roles: the signal orchestration model","volume":"149","author":"Kamimura","year":"2003","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.jaut.2024.103247_bib198","first-page":"1","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.jaut.2024.103247_bib199","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib200","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib201","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1365-2249.1997.d01-905.x","article-title":"Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: correlation with the clinical parameters","volume":"107","author":"Takizawa","year":"1997","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib202","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1164\/ajrccm.152.1.7599865","article-title":"Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis","volume":"152","author":"Girgis","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2024.103247_bib203","article-title":"Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents","volume":"1","author":"Sharp","year":"2019","journal-title":"Respir. Med. X"},{"key":"10.1016\/j.jaut.2024.103247_bib204","article-title":"A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis","author":"Baker","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2024.103247_bib205","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3389\/fimmu.2017.01228","article-title":"Multifaceted role of neuropilins in the immune system: potential targets for immunotherapy","volume":"8","author":"Roy","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2024.103247_bib206","article-title":"Neuropilin-2, the specific binding partner to ATYR1923, is expressed in sarcoid granulomas and key immune cells","volume":"201","author":"Paz","year":"2020","journal-title":"Abstract Am J Respir Crit Care Med 2020"},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib207","article-title":"Efzofitimod: a novel anti-inflammatory agent for sarcoidosis","volume":"40","author":"Baughman","year":"2023","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.jaut.2024.103247_bib208","article-title":"ATYR1923 modulates the inflammatory response in experimental models of interstitial lung disease Abstract","volume":"199","author":"Burkett","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2024.103247_bib209","first-page":"A1064","article-title":"Pre-clinical characterization of iMod. Fc, an immune-modulatory therapeutic with potentially broad application in interstitial lung diseases","volume":"197","author":"Ogilvie","year":"2018","journal-title":"Abstract. Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jaut.2024.103247_bib210","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.chest.2022.10.037","article-title":"Efzofitimod for the treatment of pulmonary sarcoidosis","volume":"163","author":"Culver","year":"2023","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib211","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/S2665-9913(23)00302-8","article-title":"Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial","volume":"6","author":"Redl","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaut.2024.103247_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152102","article-title":"Sarcoidosis incidence after mTOR inhibitor treatment","volume":"57","author":"Baker","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jaut.2024.103247_bib213","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.cr.7310017","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know","volume":"16","author":"Shi","year":"2006","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.jaut.2024.103247_bib214","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190945","article-title":"GM-CSF in inflammation","volume":"217","author":"Hamilton","year":"2020","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.jaut.2024.103247_bib215","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/thx.48.12.1230","article-title":"Correlation of GM-CSF mRNA in bronchoalveolar fluid with indices of clinical activity in sarcoidosis","volume":"48","author":"Itoh","year":"1993","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.jaut.2024.103247_bib216","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000236532","article-title":"Effect of GM-CSF on TNF-alpha and IL-1-beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis","volume":"102","author":"Terao","year":"1993","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"11","key":"10.1016\/j.jaut.2024.103247_bib217","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2217\/imt.15.79","article-title":"Manipulating regulatory T cells: a promising strategy to treat autoimmunity","volume":"7","author":"Zhang","year":"2015","journal-title":"Immunotherapy"},{"issue":"7","key":"10.1016\/j.jaut.2024.103247_bib218","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2024.103247_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103496","article-title":"Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity","volume":"70","author":"Chen","year":"2021","journal-title":"EBioMedicine"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T06:40:51Z","timestamp":1738478451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124000817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":219,"alternative-id":["S0896841124000817"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103247","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunopathogenesis of sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103247"}}